Clinical Trials Browser

Phase 1/2 × INCB039110 × Gastrointestinal × Clear all

NCT01858883 2019-07-18

Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms